Eden Research (LON:EDEN) Stock Price Down 3.3% – What’s Next?

Shares of Eden Research plc (LON:EDEN) fell 3.3% during mid-day trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares changed hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The stock has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The firm has a fifty day moving average of GBX 3.87 and a 200-day moving average of GBX 3.95. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26.

Insider Activity at Eden Research

In other news, insider Lykele van der Broek purchased 256,000 shares of the stock in a transaction on Thursday, February 6th. The stock was purchased at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,958.74). Also, insider Alexander John Abrey purchased 540,540 shares of the stock in a transaction on Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,362.19). Insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.